Oxford BioMedica PLC (OXB.L)
1.60GBp
11:30am EDT
-0.03p (-1.54%)
1.62p
1.62p
--
--
1,933,771
2,773,855
2.88p
1.45p
OXB.L
About
Overall
| Beta: | 0.86 |
| Market Cap (Mil.): | £23.01 |
| Shares Outstanding (Mil.): | 1,416.15 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| OXB.L | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 34.45 | 32.18 |
| EPS (TTM): | -0.01 | -- | -- |
| ROI: | -45.24 | -2.81 | 18.91 |
| ROE: | -46.67 | -3.51 | 19.87 |
Oxford BioMedica pauses some trials after finding potential impurities
- Gene-based biopharmaceutical company Oxford BioMedica said it put some of its trials on hold, after the company detected very low concentrations of potential impurities in a raw material.
Oxford BioMedica pauses some trials after finding potential impurities
June 3 - Gene-based biopharmaceutical company Oxford BioMedica said it put some of its trials on hold, after the company detected very low concentrations of potential impurities in a raw material.
BRIEF-Oxford Biomedica says annual revenue flat on year
LONDON, Feb 27 - Oxford BioMedica PLC : * Net loss of £8.7 million (2011: £12.6 million) * Revenue of £7.8 million (2011: £7.7 million) * Seeing more interest than ever in personalised medicines and niche disease
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: Edison Investment Research
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
